Marksans Pharma (MARKSANS.BO) Earnings Analysis
Marksans Pharma (MARKSANS.BO) next reports earnings on 2026-08-06, consensus EPS 3.3 INR. It has beaten estimates in 1/1 recent quarters (100%). Trailing P/E 26.75.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does MARKSANS.BO next report earnings?
| Next earnings date | 2026-08-06 |
|---|---|
| Consensus EPS estimate | 3.3 INR |
| Revenue estimate | 8.50B |
MARKSANS.BO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-26 | 3.25 INR | n/a | n/a | n/a |
| 2026-02-05 | 2.5 INR | 2.4 INR | +4.2% | Beat |
| 2025-11-13 | 2.2 INR | n/a | n/a | n/a |
| 2025-05-19 | 2 INR | n/a | n/a | n/a |
Beat rate: 1/1 (100%) over reported quarters with consensus data.
MARKSANS.BO valuation and analyst view
| Trailing P/E | 26.75 |
|---|---|
| Trailing EPS | 9.225 INR |
| Price / book | 3.70 |
| Dividend yield | 0.32% |
| Market cap | 108.93B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Marksans Pharma (MARKSANS.BO)'s next earnings date?
Marksans Pharma is next scheduled to report on 2026-08-06, with a consensus EPS estimate of 3.3 INR and revenue estimate of 8.50B.
Did MARKSANS.BO beat earnings last quarter?
Consensus estimate data was not available for MARKSANS.BO's 2026-05-26 report.
What is MARKSANS.BO's earnings track record?
Over the last 1 reported quarters with consensus data, MARKSANS.BO beat estimates 1 times (100%).
What is MARKSANS.BO's current P/E ratio and EPS?
MARKSANS.BO trades at a trailing P/E of 26.75 on trailing EPS of 9.225243601460505 INR.
What do analysts rate MARKSANS.BO?
MARKSANS.BO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.